KLÁNOVÁ, M., KAZANTSEV, D., POKORNÁ, E., ZIKMUND, T., KAROLOVÁ, J., BEHOUNEK, M., RENESOVA, N., SOVILJ, D., KELEMEN, C. D., HELMAN, K., JAKSA, R., HAVRANEK, O., ANDĚRA, L., TRNĚNÝ, M., KLENER, P. Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics. 2022, 21(1), 89-99. ISSN 1535-7163. E-ISSN 1538-8514. Dostupné z: https://doi.org/10.1158/1535-7163.MCT-21-0511.